Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 114

Emailed: 0

PDF Downloaded: 47


Jana, Ghosh, Debnath, Ghosh, Karmakar, and Haldar: Prevalence of hypogonadism in type 2 diabetes mellitus associated with or without obesity: An observational study


Introduction

Sexual health & capability are significant determinants of personal satisfaction. Sexual issues are distressingly normal in men with type 2 diabetes Mellitus (DM). A few overviews have shown halfway or complete disappointment of erection in 30 to 60% of patients1, 2, 3, 4 with ejaculatory irregularities in more modest proportion. 5 Erectile brokenness (ED) in diabetic men might be because of vascular illness, autonomic neuropathy, hypogonadism, drugs, mental causes, genital diseases (regularly contagious) or a mix of these. Hypogonadism is a clinical term which portrays a lessened utilitarian action of the balls for example the testicles & ovaries in guys & females, separately. That might bring about lessened sex chemical biosynthesis & weakened gamete creation & additionally guideline. Low androgen (for example testosterone) levels are alluded to as hypoandrogenism & low estrogen (for example estradiol) as hypoestrogenism, & may happen as side effects of hypogonadism in the two genders. It is overall progressively perceived as a significant heath concern & connected with extensive variety of clinical, psychosocial issues, & relational relationship. Male hypogonadism is a nonexclusive term used to depict an assortment of confusion of male regenerative framework. Male hypogonadism ought to be analyzed exclusively in men who have clinical signs & side effects that are predictable with androgen lack, & biochemical androgen lack affirmed by unequivocally low serum testosterone levels. 6 Polls like The Holy person Louis College Androgen Lack in the Maturing Male (ADAM) questionnaire 7 have been created to evaluate androgen inadequacy. These surveys, notwithstanding, need explicitness yet have sensible responsiveness within the sight of a low testosterone level.

It has been accounted for that testosterone levels are lower in diabetic men contrasted & nondiabetic subjects. 8, 9 It has likewise been accounted for that hypogonadism is related with type 2 DM & expanded weight & corpulence in a significant number of men.10 Yet, there are not many examinations about the amount it is predominant in subjects with diabetes or expanded weight or both. Acknowledgment of predominance of hypogonadism in these two issues might assist us with chalking out the anticipation the executives methodologies before it advanced to irreversible stage.

Aims & Objectives

  1. 1. To determine the prevalence of hypogonadism in adult men with type 2 diabetes mellitus with or without obesity.

  2. To determine the prevalence of hypogonadism in age. matched non diabetic, nonobese individuals

  3. To assess the impact of duration of diabetes on development of hypogonadism.

Materials and Methods

It was a cross sectional observational comparative study, conducted at inpatient & outpatient departments of Medicine & inpatient department of Departments of Endocrinology & Cardio-Diabetes clinic in IPGME&R & SSKM Hospital, Kolkata after getting approval of Institutional Ethics Committee.

A total of 108 male subjects within the age group 30-65 were included in the study after taking proper consent. Among them 54 were cases those were known to have type 2 diabetes mellitus & associated with or without overweight / obesity. The rest were controls, age & sex matched subjects without any known history of type 2 diabetes mellitus & non-obese. Criteria for diagnosis of diabetes were taken from ADA Guidelines 2010 & obesity or overweight was defined according to guidelines of BMI in Asian Indian population.

Inclusion criteria

  1. Age- 30-65 years.

  2. Presence of diabetes

  3. Obese / overweight.

  4. Patients consenting to answer to questionnaire related to their sexual matters.

Exclusion criteria

  1. Acutely ill patients.

  2. Alcoholic subjects.

  3. History of surgery at lower abdominal or inguinal region

  4. History of following drug intake in last 6 months: ketoconazole, corticosteroids, anabolic steroid, spironolactone, cimetidine, phenytoin, flutamide, cancer chemotherapy, GnRH agonist, androgens.

  5. History of mumps orchitis.

  6. Hypothyroidism.

Detailed history, clinical examination, biochemical investigations (Serum FT4 & TSH, Serum LH & FSH, Serum urea, creatinine, Liver function test, HIV serology) done in all the subjects. Questionnaire based on “The Saint Louis University Androgen Deficiency in Aging Males (ADAM) Questionnaire” & biochemical examination viz. sex hormone binding globulin (SHBG) & total testosterone in serum were used to detect presence of hypogonadism in the included cases & controls.

St Louis ADAM questionnaire proposed by Morley et al.

  1. Do you have a decrease in libido (sex drive ?

  2. Do you have a lack of energy?

  3. Do you have a decrease in strength and/or endurance?

  4. Have you lost height?

  5. Have you noticed a decreased enjoyment of life?

  6. Are you sad and/or grumpy?

  7. Are your erections less strong?

  8. Have you noticed a recent deterioration in your ability to play sports?

  9. Are you falling asleep after dinner?

  10. Has there been a recent deterioration in your work performance?

All questions are answered ‘yes’ or ‘no’.

Hypogonadism was defined by the presence of at least three sexual symptoms associated with a low total testosterone level of < 11nmol/l (3.2ng/ml) & a free testosterone level of < 220pmol/l (64pg/ml).11 SHBG measurement reflects free testosterone & bioavailable testosterone. For the determination of SHBG, the assay used is a solid phase enzyme-linked immunosorbent assay (ELISA) based on the sandwich principle. 12 Statistical analysis was performed after taking the data for prevalence of male hypogonadism in diabetes with or without obesity / overweight with standard statistical software (SPSS) version 16.

Result

Age related hypogonadism in cases & controls

The study population had 54 cases. Among those 24 were ≤ 50 years old, out of which 2 cases (8.3%) had hypogonadism. 30 cases were > 50 years old, out of which 11 cases (36.6%) had hypogonadism. Fisher’s Exact test showed it is statistically significant (Table 1). Among controls 27 were ≤ 50 years old, out of which 1 case (3.7%) had hypogonadism, rest were > 50 years old, out of which 2 cases (7.4%) had hypogonadism. It was not significant.

Table 1

Hypogonadism

≤50 years

>50 years

Total

Absent

22

19

41

Present

2

11

13

Total

24

30

54

Association of hypogonadism with duration of diabetes

During analyzing the duration of diabetes mellitus of the cases (diabetics), it was seen that among 54 diabetic cases 24 cases had less than 5 years duration, 15 cases had 5-10 years duration, & 15 cases had more than 10 years duration (Table 2).

Table 2

Duration of diabetes

No. of cases

Percentage

<5 years

24

44.4

5-10 years

15

27.8

>10 years

15

27.8

Total

54

100

It was again seen that among the15 cases who had > 10 years duration of diabetes, 10 cases (66.6%) had hypogonadism. In 2 tailed Pearson’s correlation it is significant (0.001) but weakly correlated (Figure 1).

Figure 1
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/47201f9f-2a64-4b99-b05a-4458f1c06579image1.png

Association of hypogonadism with BMI

The study showed among the cases 26 had increased BMI (≥23), out of which 10 cases (38.46%) had hypogonadism, which is statistically significant (0.026) (Table 3).

Table 3

Hypogonadism

BMI < 23

BMI ≥ 23

Total

Absent

25

16

41

Present

3

10

13

Total

28

26

54

Comparison of hypogonadism in cases & controls

The study shows that out of 54 diabetic cases, hypogonadism was found in 13 (24.07%) subjects. Whereas in control group (54 subjects), hypogonadism was present in only 3 (5.5%) (Table 2).

Figure 2
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/47201f9f-2a64-4b99-b05a-4458f1c06579image2.png

Total testosterone in cases

In our study out of 54 cases, 12 subjects (22.2%) had total testosterone <3.2ng/ml; 3 cases (5.5%) had total testosterone 3.2-4.0 ng/ml & 39 cases (72.2%) had total testosterone >4.0 ng/ml (Figure 3).

Figure 3

Total testosterone

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/47201f9f-2a64-4b99-b05a-4458f1c06579image3.png

Free testosterone in cases

In our study out of 54 cases, 41 cases had free T level <64pg/ml whereas 41 cases had free T level ≥64pg/ml (Figure 4).

Figure 4

Free testosterone

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/47201f9f-2a64-4b99-b05a-4458f1c06579image4.png

Discussion

Diabetes mellitus (DM) is known to make serious ramifications on sexual capability due its consequences for both neurologic & vascular parts. Also, the presence of ineffectively controlled diabetes might build the dismalness related with the treatment of erectile brokenness. 13 The etiology of erectile brokenness in diabetes is multi-factorial, including neuropathy, vascular illness, metabolic control, nourishment, endocrine problems, psychogenic elements, & hostile to diabetes drugs. 14 In the current review, we contrasted 54 analyzed diabetic male & 54 non-diabetic men suitably coordinated. Our review exhibited hypogonadism to be a typical complexity in type 2 diabetic men transcendently without miniature or large scale vascular confusions or whatever other condition that could cause sexual brokenness contrasted with age matched non-diabetic control populace. Hypogonadism in the review not entirely set in stone by estimating the Complete Testosterone (TT) level & the degree of Sex Chemical Restricting Globulin (SHBG). In this review it was seen that the Absolute Testosterone & free Testosterone levels were fundamentally lower in diabetic patients in contrast with control solid subjects. This shows the relationship of hypogonadism in patients of diabetes mellitus. Dhindsa et al (2004) had exhibited in their review, event of hypogonadotrophic hypogonadism in type-2 DM patients. The commonness of hypogonadism in their review was 33% & many were related with hypogonadotrophism 9. In our review the commonness of hypogonadism was 24.07% in diabetics in contrast with 5.5% in charge, who were non diabetic. In this examination, we observed that there is a tremendous distinction of sex steroid levels between type 2 DM men & control bunch. This exposes the significant job of hormonal change in the causation of sexual brokenness in diabetes mellitus. This is of specific significance on the grounds that viable treatment choices are accessible for such sexual problems. In our review it was likewise seen that a critical number of diabetic men had low aggregate & free testosterone levels. The numbers in the non-diabetic partners were altogether low. BMI was likewise estimated for all patients & there was critical relationship between high BMI & hypogonadism. Among the cases, the subjects with BMI ≥23, had expanded commonness of hypogonadism (38.46%). Hypogonadism likewise increments with longer length of diabetes. This is likewise as opposed to the concentrate by Dandona et al 15 where no huge affiliation was found between span of diabetes & event of hypogonadism.

Conclusion

We conclude that prevalence of hypogonadism in diabetic subjects was significantly more than age matched control population. Increased duration of diabetes & increased age of the patients were associated with increased prevalence of hypogonadism. In our study it was also found that in addition to diabetes, persons who were also obese or overweight had increased prevalence of hypogonadism.

Limitations

  1. Larger sample size would have been better for more representation

  2. Follow-up studies are essential to establish trends in hypogonadism with increasing age & duration of type 2 diabetes mellitus.

Source of Funding

None.

Conflict of Interest

None.

Acknowledgement

Remaining grateful to the Department of General Medicine & Department of Endocrinology, IPGMER, Kolkata.

References

1 

G Defeudis R Mazzilli M Tenuta G Rossini V Zamponi S Olana Erectile dysfunction & diabetes: A melting pot of circumstances & treatmentsDiabetes Metab Res Rev2021382e349410.1002/dmrr.3494

2 

WH Kang MNM Sithik JK Khoo YG Ooi QH Lim LL Lim Gaps in the management of diabetes in Asia: A need for improved awareness and strategies in men's sexual healthJ Diabetes Investig20221312194557

3 

DK Mcculloch IW Campbell FC Wu RJ Prescott BF Clarke The prevalence of diabetic impotenceDiabetologia198018427983

4 

D Fedele C Coscelli F Santeusanio A Bortolotti L Chatenoud E Colli Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei DiabeticiDiabetes Care1998211119737

5 

CG Fairburn FC Wu DK Mcculloch DQ Borsey DJ Ewing BF Clarke The clinical features of diabetic impotence: a preliminary studyBr J Psychiatry19821404475210.1192/bjp.140.5.447

6 

S Bhasin G R Cunningham F J Hayes AM Matsumoto PJ Snyder RS Swerdloff Testosterone therapy in adult men with androgen deficiency syndromes: An Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab200691619952010

7 

JE Morley E Charlton P Patrick FE Kaiser P Cadeau D Mccready Validation of a screening questionnaire for androgen deficiency in aging malesMetabolism2000499123942

8 

D Kapoor CJ Malkin KS Channer TH Jones Androgens, insulin resistance and vascular disease in menClin Endocrinol (Oxf)200563323950

9 

S Dhindsa S Prabhakar M Sethi A Bandyopadhyay A Chaudhuri P Dandona Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetesJ Clin Endocrinol Metab2004891154628

10 

SA Saboor-Aftab S Kumar TM Barber The role of obesity & type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadismClin Endocrinol (Oxf)20137833307

11 

CW Frederick A Tajar JM Beynon SR Pye AJ Silman JD Finn Identification of late-onset hypogonadism in middle-aged and elderly menN Engl J Med201036321235

12 

MA Tawfeek EM Alfadhli AM Alayoubi HA El-Beshbishy FA Habib Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitusBMC Womens Health20091711810.1186/s12905-017-0373-3

13 

WO Brant AJ Bella TF Lue KR Feingold B Anawalt MR Blackman Sexual Dysfunction in diabetesEndotext [Internet].South Dartmouth (MA): MDText.com, Inc.2006

14 

AI Vinik RE Maser BD Mitchell R Freeman Diabetic autonomic neuropathyDiabetes Care2003265155379

15 

P Dandona S Dhindsa Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and ObesityJ Clin Endocrinol Metab2011969264351



jats-html.xsl

© 2024 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)